M14.89 — Arthropathies in other specified diseases classified elsewhere, multiple sites

BillableUnspecified

Is M14.89 billable?

Yes, but M14.89 is an unspecified code. M14.89 is a valid, billable ICD-10-CM code for encounters from October 1, 2026 through September 30, 2027. However, M14.89 is an unspecified or catch-all code. Payers apply additional scrutiny to unspecified codes and many deny them when the medical record supports a more specific option, so check the documentation before selecting M14.89 — the more specific alternatives are listed below.

More specific alternatives

M14.89 at a glance

Code	M14.89
Description	Arthropathies in other specified diseases classified elsewhere, multiple sites
Billable	Yes
Code set	ICD-10-CM FY2027
Valid for encounters	October 1, 2026 – September 30, 2027

What Medicare edits apply to M14.89?

The Medicare Code Editor screens inpatient claims before they are grouped. These edits name M14.89 directly.

Manifestation code — never sequenced first — MCE edit 6

This code describes a manifestation of an underlying disease. The underlying condition must be sequenced before it, so it can never be the principal or first-listed diagnosis.

Which MS-DRGs does M14.89 group to?

M14.89 sits in MDC 08 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

553Bone Diseases and Arthropathies with MCCmedical
554Bone Diseases and Arthropathies without MCCmedical

How is M14.89 listed in the Alphabetic Index?

The Alphabetic Index lists these routes under M14.8, the nearest indexed parent of M14.89. Use them to find the family, then select the specific code.

Arthropathy › in › acromegaly
Arthropathy › in › amyloidosis
Arthropathy › in › endocrine disease NOS
Arthropathy › in › hemochromatosis
Arthropathy › in › hyperthyroidism
Arthropathy › in › hypothyroidism
Arthropathy › in › metabolic disease NOS
Arthropathy › gouty › in › Lesch-Nyhan syndrome

Excludes1 — never code together — inherited from M14

The conditions below can never be reported together with M14.89 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

arthropathy in:
diabetes mellitus (E08-E13 with .61-)
hematological disorders (M36.2-M36.3)
hypersensitivity reactions (M36.4)
neoplastic disease (M36.1)
neurosyphillis (A52.16)
sarcoidosis (D86.86)
enteropathic arthropathies (M07.-)
juvenile psoriatic arthropathy (L40.54)
lipoid dermatoarthritis (E78.81)

Code first — inherited from M14.8

The underlying condition below must be sequenced before M14.89. M14.89 describes a manifestation and cannot be the principal or first-listed diagnosis.

underlying disease, such as:
amyloidosis (E85.-)
erythema multiforme (L51.-)
erythema nodosum (L52)
hemochromatosis (E83.11-)
hyperparathyroidism (E21.-)
hypothyroidism (E00-E03)
sickle-cell disorders (D57.-)
thyrotoxicosis [hyperthyroidism] (E05.-)
Whipple's disease (K90.81)

Excludes2 — not included here — inherited from Chapter 13

The conditions below are not part of M14.89, but a patient may have both at the same time. When documentation supports it, M14.89 and the excluded code may both be reported.

arthropathic psoriasis (L40.5-)
certain conditions originating in the perinatal period (P04-P96)
certain infectious and parasitic diseases (A00-B99)
compartment syndrome (traumatic) (T79.A-)
complications of pregnancy, childbirth and the puerperium (O00-O9A)
congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
endocrine, nutritional and metabolic diseases (E00-E88)
injury, poisoning and certain other consequences of external causes (S00-T88)
neoplasms (C00-D49)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

How long has M14.89 existed?

M14.89 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.